Is screening for chronic obstructive pulmonary disease justified?

Preventive Medicine

Volumn 26, Issue 4, 1997, Pages 466-472

  Badgett, Robert G ^a   Tanaka, David J ^a  

^a NONE

Author keywords

Emphysema; Screening; Smoking cessation; Spirometry

Indexed keywords

ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; EMPHYSEMA; HUMAN; PRIORITY JOURNAL; SCREENING; SMOKING CESSATION; SPIROMETRY;

EID: 0031193314     PISSN: 00917435     EISSN: None     Source Type: Journal    
DOI: 10.1006/pmed.1997.0177     Document Type: Article

References (86)

1. Crapo R O. Pulmonary-function testing. N Engl J Med. 331:1994;25-30.
2. Enright P L, Hyatt R E. Office spirometry: a practical guide to the selection and use of spirometers. 1987;Lea-Febiger, Melvern. p. 1-.
3. Macklem P T, Permutt S. The lung in transition between health and disease. 1979;Dekker, New York. p. 398-.
4. Hayward R S, Steinberg E P, Ford D E, Roien M F, Roach K W. Preventive care guidelines:1991. Ann Intern Med. 114:1991;758-783.
5. Sox H C Jr. Preventive health services in adults. N Engl J Med. 330:1994;1589-1595.
6. Guide to clinical preventive services. 1996;Williams & Wilkins, Baltimore.
7. The Canadian guide to clinical preventive health care. 1994;Canada Communication Group, Ottawa.
8. Hayward R SA, Steinbery E P, Ford D E. Preventive care guidelines. Ann Intern Med. 115:1991;406-407.
9. Sackett D L, Haynes R B, Guyatt G H, Tugwell P. Clinical epidemiology: a basic science for clinical medicine. 1991;Little, Brown, Boston. p. 168-.
10. Cadman D, Chambers L, Feldman W, Sackett D. Assessing the effectiveness of community screening programs. JAMA. 251:1984;1580-1585.
11. MMWR. 42:1993;891-900.
12. Murray J F, Nadel J A. Textbook of respiratory medicine. 1988;Saunders, Philadelphia. p. 1001-1003.
13. Foxman B, Lohr K N, Brook R H, Goldberg G A, Rosenthal M, Sloss E. Conceptualization and measurement of physiologic health for adults: chronic obstructive airway disease. 1982;Rand Corp, Santa Monica. p. 51-.
14. Black E R, Mushlin A I, Griner P F, Suchman A L, James R L, Schoch D R. Predicting the need for hospitalization of ambulatory patients with pneumonia. J Gen Intern Med. 6:1991;394-400.
15. Koivula I, Sten M, Makela P H. Risk factors for pneumonia in the elderly. Am J Med. 96:1994;313-320.
16. Barker W H, Mullooly J P. Pneumonia and influenza deaths during epidemics. Arch Intern Med. 142:1982;85-89.
17. Beaty T H, Newill A, Cohen B H, Tockman M S, Bryant S H, Spurgeon H A. Effects of pulmonary function on mortality. J Chron Dis. 38:1985;703-710.
18. Islam S S, Schottenfeld D. Declining FEV1 and chronic productive cough in cigarette smokers: a 25-year prospective study of lung cancer incidence in Tecumsah, Michigan. Cancer Epidemiol Biomarkers Prev. 3:1994;289-298.
19. Tockman M S, Antionisen N R, Wright E C, Donithan M G. Airways obstruction and the risk for lung cancer. Ann Intern Med. 106:1987;512-518.
20. Kuller L H, Ockene J, Meilahn, Svendsen K H. Relation of forced expiratory volume in one second (FEV1) to lung cancer mortality in the multiple risk factor intervention Trial (MRFIT). Am J Epidemiol. 132:1990;265-274.
21. Nomura A, Stemmermann G N, Chyou P, Marcus E B, Buist A S. Prospective study of pulmonary function and lung cancer. Am Rev Respir Dis. 144:1991;307-311.
22. Lange P, Nyboe J, Appleyard M, Jensen G, Schnohr P. Ventilatory function and chronic mucous hypersecretion as predictors of death from lung cancer. Am Rev Respir Dis. 141:1990;613-617.
23. Skillrud D M, Offord K P, Miller R D. Higher risk of lung cancer in chronic obstructive pulmonary disease: a prospective, matched, controlled study. Ann Intern Med. 105:1986;503-507.
24. Cohen B H, Diamond E L, Graves C G, Kreiss P, Levy D A, Menkes H A. A common familial component in lung cancer and chronic obstructive pulmonary disease. Lancet. ii:1977;523-526.
25. Cohen B H. Chronic obstructive pulmonary disease: a challenge in genetic epidemiology. Am J Epidemiol. 112:1980;274-288.
26. Tockman M S, Pearson J D, Fleg J L, Metter E J, Kao S Y, Rampal K G. Rapid decline in FEV1: a new risk factor for coronary heart disease mortality. Am J Crit Care Med. 151:1995;390-398.
27. Ebi-Kryston K l. Respiratory symptoms and pulmonary function as predictors of 10 year mortality from respiratory disease, cardiovascular disease, and all causes in the Whitehall Study. J Clin Epidemiol. 41:1988;251-260.
28. Farchi G, Menotti A, Conti S. Coronary risk factors and survival probability from coronary and other causes of death. Am J Epidemiol. 126:1987;400-408.
29. Krzyzanowski M, Wysocki K. The relationship of thirteen-year mortality to ventilatory impairment and other respiratory symptoms: the Crakow Study. Int J Epidemiol. 15:1986;56-64.
30. Cullen K, Stenhouse N S, Wearne K L, Welborn T A. Multiple regression analysis of risk factors for cardiovascular disease and cancer mortality in Busselton, Western Australia - 13 year study. J Chron Dis. 36:1983;371-377.
31. Friedman G D, Klatsky A L, Siegelaub A B. Lung function and risk of myocardial infarction and sudden cardiac death. N Engl J Med. 294:1976;1071-1075.
32. Cook D G, Shaper A G. Breathlessness, lung function and the risk of heart attack. Eur Heart J. 9:1988;1215-1222.
33. Strachan D P. Ventilatory function as a predictor of fatal stroke. Br Med J. 302:1991;84-87.
34. Weinberger S E. Recent advances in pulmonary medicine. N Engl J Med. 328:1993;1389-1397.
35. Saint S, Bent S, Vittinghoff E, Grady D. Antibiotics in chronic obstructive pulmonary disease exacerbations: a meta-analysis. JAMA. 273:1995;957-960.
36. Bolan G, Broome C V, Facklam R R, Plikaytis B D, Fraser D W, Schlech W F. Pneumococcal vaccine efficacy in selected populations in the United States. Ann Intern Med. 104:1986;1-6.
37. Shapiro E D, Berg A T, Austrian R, Schroeder D, Parcelss V, Margolis A. The protective effect of polyvalent pneumococcal polysaccharide vaccine. N Engl J Med. 325:1991;1453-1460.
38. Butler J C, Breiman R F, Campbell J F, Lipman H B, Broome C V, Facklam R R. Pneumococcal polysaccharide vaccine efficacy. JAMA. 270:1993;1826-1831.
39. Barker W H, Mullooly J P. Influenza vaccination of elderly persons: reduction in pneumonia and influenza hospitalizations and death. Arch Intern Med. 244:1980;2547-2549.
40. Boyko E J, Alderman B W. The use of risk factors in medical diagnosis: opportunities and cautions. J Clin Epidemiol. 43:1990;851-858.
41. 1. Chest. 105:1994;1406-1410.
42. 1. JAMA. 272:1994;1497-1505.
43. Dompeling E, van Schayck C P, van Grunsven P M, van Herwaarden C LA, Akkermans R, Molema J. Slowing the deterioration of asthma and chronic obstructive pulmonary disease observed during bronchodilator therapy by adding inhaled corticosteroids. Ann Intern Med. 118:1993;770-778.
44. Pauwels R A, L'fdahl C-G, Pride N B, Postma D S, Laitinen L A, Ohlsson S V. European Respiratory Society study on chronic obstructive pulmonary disease (EUROSCOP): hypothesis and design. Eur Respir J. 5:1992;1254-1261.
45. Sorlie P, Lakatos E, Kannel W B. Influence of cigarette smoking on lung function at baseline and at follow-up in 14 years: the Framingham Study. J Chron Dis. 40:1987;849-856.
46. Camilli A E, Burrows B, Knudson R J, Lyle S K, Lebowitz M D. Longitudinal changes in forced expiratory volume in one second in adults: effects of smoking and smoking cessation. Am Rev Respir Dis. 135:1987;794-799.
47. Fletcher C, Peto R. The natural history of chronic airflow obstruction. Br Med J. 1:1977;1645-1648.
48. Burrows B, Knudson R J, Camilli A E, Lyle S K, Lebowitz M D. The "horse-racing effect" and predicting decline in forced expiratory volume in one second from screening spirometry. Am Rev Respir Dis. 135:1987;788-793.
49. Higgins M W, Enright P L, Kronmal R A, Schenker M B, Anton-Culver H, Lyles M. Smoking and lung function in elderly men and women. JAMA. 269:1993;2741-2748.
50. Lubin J H, Blot W J, Berrino F, Flamant R, Gillis C R, Kunz M. Modifying risk of developing lung cancer by changing habits of cigarette smoking. Br Med J. 288:1984;1953-1956.
51. Doll R, Peto R. Mortality in relation to smoking: 20 years' observations on male British doctors. Br Med J. 2:1976;1525-1536.
52. Rogot E, Murray J L. Smoking and causes of death among U.S veterans: 16 years of observation. Public Health Rep. 95:1980;213-222.
53. Vliestra R E, Kronmal R A, Oberman A. Effect of cigarette smoking on survival of patients with angiographically documented coronary artery disease: report from the CASS registry. J Am Med Assoc. 255:1986;1023-1027.
54. LaCroix A Z, Lang J, Scherr P, Wallace R B, Cornoni-Huntley J, Berkman L. Smoking and mortality among older men and women in three communities. N Engl J Med. 324:1991;1619-1625.
55. Hermanson B, Omenn G S, Kronmal R A, Gersh B J. Beneficial six-year outcome of smoking cessation in older men and women with coronary artery disease. N Engl J Med. 319:1988;1365-1369.
56. Cummings S R, Rubin S M, Oster G. The cost-effectiveness of counseling smokers to quit. JAMA. 261:1989;75-79.
57. Oster G, Huse D M, Delea T E, Colditz G A. Cost-effectiveness of nicotine gum as an adjunct to physicians advice against cigarette smoking. JAMA. 256:1986;1315-1318.
58. Krumholz H M, Cohen B J, Tsevat J, Pasternak R C, Weinstein M C. Cost-effectiveness of a smoking cessation program after myocardial infarction. J Am Coll Cardiol. 22:1993;1697-1702.
59. Li V C, Kim Y J, Ewart C K, Terry P B, Cuthie J C, Wood J. Effects of physician counseling on the smoking behavior of asbestos-exposed workers. Prev Med. 13:1984;462-476.
60. Risser N L, Belcher D W. Adding spirometry, carbon monoxide, and pulmonary symptom results to smoking cessation counseling. J Gen Intern Med. 5:1990;16-22.
61. Segnan N, Ponti A, Battista R N, Rosso S, Shapiro S H, Aimar D. A randomized trial of smoking cessation interventions in general practice in Italy. Cancer Causes Control. 2:1991;239-246.
62. Hepper N GG, Drage C W, Davies S F, Rupp W M, LaMothe J, Schoenfelder P G, Munson P. Chronic obstructive lung disease: a community-oriented program including professional education and screening by a voluntary health agency. Am Rev Respir Dis. 121:1980;97-104.
63. Petty T L, Pierson D J, Dick N P, Hudson L D, Walker S H. Follow-up of a prevalence study for chronic bronchitis and chronic airflow obstruction. Am Rev Respir Dis. 114:1976;881-890.
64. Loss R W, Hall W J, Speers D M. Evaluation of early airway disease in smokers: cost effectiveness of pulmonary function testing. Am J Med Sci. 278:1979;27-37.
65. Buist A S, Sexton G J, Nagy J M, Ross B B. The effect of smoking cessation and modification on lung function. Am Rev Respir Dis. 114:1976;115-122.
66. Morris J F, Temple W. Spirometic "lung age" for motivating smoking cessation. Prev Med. 14:1985;655-662.
67. Freedman S, Raffin T A, Rothkopf M H, Eddy D M. The value of a stage prop: screening for chronic obstructive pulmonary disease. Chest. 85:1984;406-407.
68. Am Rev Respir Dis. 128:1983;768-774.
69. Frank E, Winkleby M A, Altman D G, Rockhill B, Fortman S P. Predictors of physicians' smoking cessation advice. JAMA. 266:1991;3139-3144.
70. Anda R F, Remington P L, Sienko D G, Davis R M. Are physicians advising smokers to quit? The patient's perspective. JAMA. 257:1987;1916-1919.
71. Valente C M, Sobal J, Muncie H L. Health promotion: physicians' beliefs, attitudes, and practices. Am J Prev Med. 2:1982;82-88.
72. Kottke T E, Battista R N, DeFriese G H, Brekke M L. Attributes of successful smoking cessation interventions in medical practice. JAMA. 259:1988;2882-2889.
73. Silagy C, Mant D, Fowler G, Lodge M. Meta-analysis on efficacy of nicotine replacement therapies in smoking cessation. Lancet. 343:1994;139-142.
74. 9th rev. Clinical modification. 1978;Edwards, Ann Arbor. p. 233-.
75. Physicians' current procedure terminology. 1994;American Medical Assoc, Chicago. p. 37-.
76. Anonymous. Cigarette smoking among adults - United States, 1993. MMWR. 43:1994;925-929.
77. Fiore M C. The new vital sign: assessing and documenting smoking status. JAMA. 266:1991;3183-3184.
78. Hnatiuk O, Moores L, Loughney T, Torrington K. Evaluation of internists' spirometric interpretations. J Gen Intern Med. 11:1996;204-208.
79. Haynes R B, Sackett D L, Taylor D W, Gibson E S, Johnson A L. Increased absenteeism from work after detection and labeling of hypertensive patients. N Engl J Med. 299:1978;741.
80. Anonymous. Nicotine patches. Med Lett. 34:1992;37-38.
81. Badgett O G, Tanaka R J, Hunt D K, Jelley M J, Feinberg L E, Steiner J F, Petty T L. The clinical evaluation for diagnosing obstructive airways disease in high risk patients. Chest. 106:1994;1427-1431.
82. Holleman D R, Simel D L, Goldberg J S. Diagnosis of obstructive airways disease from the clinical examination. J Gen Intern Med. 8:1993;63-68.
83. Badgett R G, Tanaka D J, Hunt D K, Jelley M J, Feinberg L E, Steiner J F, Petty T L. Can moderate chronic obstructive pulmonary disease be diagnosed by historical and physical findings alone? Am J Med. 94:1993;188-196.
84. Holleman D R, Simel D L. Does the clinical examination predict airflow limitation? JAMA. 273:1995;313-319.
85. Am Rev Respir Dis. 144:1991;1202-1218.
86. McGinnis J M, Foege W H. Actual causes of death in the United States. JAMA. 270:1993;2207-2212.